ATE198513T1 - Ptpalpha-bestimmung in der tumordiagnose und - prognose - Google Patents

Ptpalpha-bestimmung in der tumordiagnose und - prognose

Info

Publication number
ATE198513T1
ATE198513T1 AT95922516T AT95922516T ATE198513T1 AT E198513 T1 ATE198513 T1 AT E198513T1 AT 95922516 T AT95922516 T AT 95922516T AT 95922516 T AT95922516 T AT 95922516T AT E198513 T1 ATE198513 T1 AT E198513T1
Authority
AT
Austria
Prior art keywords
sample
alpha
pct
ptp
prognosis
Prior art date
Application number
AT95922516T
Other languages
English (en)
Inventor
Karim Tabiti
Catherine J Pallen
Original Assignee
Inst Of Molecul & Cell Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Of Molecul & Cell Biology filed Critical Inst Of Molecul & Cell Biology
Application granted granted Critical
Publication of ATE198513T1 publication Critical patent/ATE198513T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT95922516T 1994-06-10 1995-06-06 Ptpalpha-bestimmung in der tumordiagnose und - prognose ATE198513T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9411671A GB9411671D0 (en) 1994-06-10 1994-06-10 Tumor diagnosis and prognosis
PCT/EP1995/002166 WO1995034818A1 (en) 1994-06-10 1995-06-06 Tumor diagnosis and prognosis

Publications (1)

Publication Number Publication Date
ATE198513T1 true ATE198513T1 (de) 2001-01-15

Family

ID=10756541

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95922516T ATE198513T1 (de) 1994-06-10 1995-06-06 Ptpalpha-bestimmung in der tumordiagnose und - prognose

Country Status (7)

Country Link
US (1) US5888746A (de)
EP (1) EP0764272B1 (de)
AT (1) ATE198513T1 (de)
AU (1) AU2738195A (de)
DE (1) DE69519796T2 (de)
GB (1) GB9411671D0 (de)
WO (1) WO1995034818A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040005646A1 (en) * 2002-03-26 2004-01-08 Beata Lecka-Czernik Use of the S2-6 gene product as a diagnostic marker for cancer detection
US20040229299A1 (en) * 2002-05-21 2004-11-18 Badal M. Youssouf Intracellular complexes as biomarkers
US20040224337A1 (en) * 2003-03-04 2004-11-11 Erik Foehr Use of biomolecular targets in the treatment and visualization of tumors
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
EP2363205A3 (de) 2006-01-11 2014-06-04 Raindance Technologies, Inc. Mikrofluidische Vorrichtungen Und Verfahren Zur Verwendung Bei Der Bildung Und Kontrolle Von Nanoreaktoren
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2530168B1 (de) 2006-05-11 2015-09-16 Raindance Technologies, Inc. Mikrofluidische Vorrichtungen
EP2077912B1 (de) 2006-08-07 2019-03-27 The President and Fellows of Harvard College Fluorkohlenstoffemulsionsstabilisierende tenside
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
WO2010009365A1 (en) 2008-07-18 2010-01-21 Raindance Technologies, Inc. Droplet libraries
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
EP2517025B1 (de) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Verfahren zur reduzierung des austauschs von molekülen zwischen tröpfchen
CN102108365A (zh) * 2009-12-29 2011-06-29 上海新号源生物科技有限公司 一组恶性肿瘤中突变PTPα基因及其应用
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
JP5934657B2 (ja) 2010-02-12 2016-06-15 レインダンス テクノロジーズ， インコーポレイテッド デジタル検体分析
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
WO2012045012A2 (en) 2010-09-30 2012-04-05 Raindance Technologies, Inc. Sandwich assays in droplets
EP3859011A1 (de) 2011-02-11 2021-08-04 Bio-Rad Laboratories, Inc. Verfahren zur bildung gemischter tröpfchen
EP2675819B1 (de) 2011-02-18 2020-04-08 Bio-Rad Laboratories, Inc. Zusammensetzungen und verfahren für molekulare etikettierung
DE202012013668U1 (de) 2011-06-02 2019-04-18 Raindance Technologies, Inc. Enzymquantifizierung
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
EP2844768B1 (de) 2012-04-30 2019-03-13 Raindance Technologies, Inc. Digitale analyse von analyten
EP2986762B1 (de) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digitale analyse von analyten
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
CN112837815A (zh) * 2021-02-04 2021-05-25 复旦大学附属中山医院 基于Lauren分型和术后残留淋巴结评估胃癌预后的模型及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538886A (en) * 1990-07-11 1996-07-23 New York University Receptor-type phosphotyrosine phosphatase-alpha
GB9214754D0 (en) * 1992-07-10 1992-08-19 Univ Singapore Tumour treatment

Also Published As

Publication number Publication date
DE69519796T2 (de) 2001-04-19
AU2738195A (en) 1996-01-05
WO1995034818A1 (en) 1995-12-21
US5888746A (en) 1999-03-30
EP0764272B1 (de) 2001-01-03
EP0764272A1 (de) 1997-03-26
DE69519796D1 (de) 2001-02-08
GB9411671D0 (en) 1994-08-03

Similar Documents

Publication Publication Date Title
DE69519796D1 (de) PTPalpha-Bestimmung in der Tumordiagnose und -Prognose
Barnekow et al. Expression of the c-src protooncogene in human skin tumors
WO1998035985B1 (en) Protein markers for lung cancer and use thereof
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
TR199902828T2 (xx) Lizofosfolipidlerin de�i�mi� konsantrasyonlar� ile birle�tirilmi� kanser belirleme y�ntemi.
Weickmann et al. Immunological assay of pancreatic ribonuclease in serum as an indicator of pancreatic cancer
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
ATE175996T1 (de) Diagnose von krebs, dessen zellen das am tyrosin phosphorylierte crkl-protein exprimieren
EP0756488A4 (de) Tumor-suppressor-gen und verfahren zum nachweis von krebs
PT922223E (pt) Metodo para o diagnostico do cancro da prostata
Hoag et al. The production of creatine kinase isozyme BB in sera of a patient with prostatic carcinoma and in tumor homogenates
FR2780791B1 (fr) Methode de depistage ou de diagnostic d'un adenocarcinome ou d'une pathologie benigne de la prostate et procede de mise en oeuvre
ATE152629T1 (de) Diagnose von krebs-metastasen durch das mts-1 gen
DE60044350D1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
BR9914161A (pt) Métodos para detectar a presença de células de câncer de mama e de células de câncer endometrial e a presença de câncer de mama e de câncer endometrial em um paciente e kits para detectar a presença de células de neoplasia de mama e a presença de câncer de mama em uma amostra
DE69033810D1 (de) Herstellung und verwendung des menschlichen nm23-h2-proteins und dagegen gerichtete antikörper
AU3485393A (en) Immunological method for the detection of malignant tumours, and a kit for carrying out the method
Russo et al. Polyamine levels and ODC activity in intestinal-type and diffuse-type gastric carcinoma
BR9611255A (pt) ácido nucleico, processos para determinar a suscetibilidade de um paciente a câncer, para diagnosticar câncer em um paciente, para prever as perspectivas relativas do surgimento particular de um câncer em um paciente, para tratar câncer e para determinar a perda de heterozigosidade em amostra de tecido, sistema para detectar a presença ou ausência de, ou mutação, na região de cromossomo 10 humano, polipeptídeo, molécula e uso de ácido nucleico e de uma molécula.
DE69636041D1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
Zoll et al. Alterations of the c-erbB2 gene in human breast cancer
Nagai et al. Expression of autocrine motility factor receptor in cutaneous malignant melanoma
ATE143808T1 (de) Proteintyrosinphosphatase alpha - inhibitoren zur tumorbehandlung
Carrillo et al. Reverse transcriptase–polymerase chain reaction detection of circulating tumor cells in patients with melanoma: Correlation with clinical stage, tumor thickness and histological type
EP1023459A4 (de) Bestimmung der vorhandenen mengen an cyclin-abhängigem kinase-inhibitor p27 als prognostischem faktor bei krebspatienten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties